Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Femara (active ingredient: letrozole) is a prescription medication used to treat certain types of hormone receptor-positive breast cancer in postmenopausal women. It works by lowering the amount of estrogen in the body, which can help slow or stop the growth of breast cancer cells that depend on estrogen to grow.
Femara is approved for the following uses:
Femara is used as adjuvant (additional) treatment for postmenopausal women with hormone receptor-positive early breast cancer.
After surgery and, in some cases, radiation or chemotherapy, Femara helps reduce the risk of the cancer returning. It may also be prescribed after 5 years of tamoxifen therapy to provide additional protection against breast cancer recurrence.
Femara is also used to treat advanced or metastatic breast cancer in postmenopausal women.
Advanced breast cancer refers to cancer that has spread beyond the original tumor, while metastatic breast cancer has spread to other parts of the body, such as the bones, lungs, liver, or brain.
Femara is commonly prescribed for women whose cancer has progressed despite previous antiestrogen therapy, such as tamoxifen. By lowering estrogen levels, Femara can help slow the growth and spread of hormone receptor-positive breast cancer cells.
Femara belongs to a group of medications called aromatase inhibitors.
After menopause, most of the body’s estrogen is produced by an enzyme called aromatase, which converts other hormones into estrogen. Many breast cancers are hormone receptor-positive, meaning they rely on estrogen to grow and multiply.
Femara works by blocking the aromatase enzyme, significantly reducing the amount of estrogen produced in the body. With less estrogen available, hormone receptor-positive breast cancer cells receive less stimulation to grow, which can help:
Femara works gradually over time and is typically taken once daily for the length of time recommended by your healthcare provider. It is important to continue taking the medication exactly as prescribed, even if you feel well, because it helps reduce the risk of cancer recurrence and disease progression.
Femara is available as an oral tablet that is taken once daily, exactly as prescribed by your healthcare provider.
You may take Femara with or without food. Try to take your dose at the same time each day to help maintain a consistent level of the medication in your body and make it easier to remember.
Swallow the tablet whole with a glass of water. Do not take more or less than the prescribed dose, and do not take it more often than directed by your healthcare provider.
Continue taking Femara for the full length of treatment, even if you feel well. Do not stop taking the medication without first consulting your healthcare provider, as this may reduce its effectiveness.
Early Breast Cancer (Adjuvant Treatment)
For the adjuvant treatment of hormone receptor-positive early breast cancer, the recommended dose is 2.5 mg by mouth once daily.
Treatment is typically continued for 5 years, or for the duration recommended by your healthcare provider.
Extended Adjuvant Treatment
For women who have completed previous adjuvant treatment (such as tamoxifen), the recommended dose for extended adjuvant therapy is 2.5 mg once daily.
Your healthcare provider will determine how long you should continue treatment based on your individual risk of cancer recurrence and your response to therapy.
Advanced or Metastatic Breast Cancer
For the treatment of advanced or metastatic breast cancer, the usual recommended dose is 2.5 mg by mouth once daily.
Treatment is generally continued for as long as the medication remains effective and is well tolerated. Your healthcare provider will monitor your response and determine the appropriate duration of therapy.
Femara (Letrozole) is available in the following forms and strength:
Before taking Femara, tell your healthcare provider about your complete medical history, including any current or past medical conditions, allergies, and all medications you are taking. This information helps ensure the medication is safe and appropriate for you.
Femara lowers estrogen levels, which may lead to a decrease in bone mineral density over time. This can weaken your bones and increase the risk of osteoporosis and bone fractures, especially with long-term treatment.
Your healthcare provider may recommend bone density tests before and during treatment. Getting enough calcium and vitamin D, along with regular weight-bearing exercise, may help support bone health if recommended by your healthcare provider.
Do not take Femara if you are allergic to letrozole or any of the ingredients in the medication.
Tell your healthcare provider or pharmacist if you have ever had an allergic reaction to letrozole or another medication. Seek emergency medical attention immediately if you develop signs of a serious allergic reaction, including:
Before starting Femara, tell your healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements you are taking.
Some medications may interact with Femara, affecting how well it works or increasing your risk of side effects. Your healthcare provider or pharmacist can check for potential drug interactions before you begin treatment.
Femara may cause:
Until you know how the medication affects you, avoid driving, operating machinery, or performing activities that require alertness or clear vision.
Alcohol and marijuana (cannabis) may increase these effects. Avoid drinking alcohol and tell your healthcare provider if you use cannabis.
While taking Femara, some people may experience changes in certain laboratory values or health conditions, including:
Your healthcare provider may perform blood tests and monitor your blood pressure periodically during treatment to check for these changes.
Do not use Femara during pregnancy. Letrozole can harm an unborn baby.
Although Femara is intended for postmenopausal women, pregnancy may still be possible in some individuals. If you are pregnant, think you may be pregnant, or become pregnant while taking Femara, contact your healthcare provider immediately.
If there is any possibility you could become pregnant, discuss effective birth control options with your healthcare provider before starting treatment. Continue using reliable contraception during treatment and for at least 3 weeks after your last dose.
Long-term treatment with Femara may be associated with an increased risk of certain medical conditions. Your healthcare provider will monitor your overall health throughout treatment and determine whether any additional testing or follow-up is needed.
Attend all scheduled appointments and report any unusual symptoms, such as persistent bone pain, yellowing of the skin or eyes, severe fatigue, or signs of infection, to your healthcare provider promptly.
Femara begins lowering estrogen levels soon after you start taking it, but you may not notice any immediate changes because it works gradually. While the medication starts working within the first 1 to 2 weeks, it may take 4 to 6 weeks or longer for its full effects to become apparent. Continue taking Femara exactly as prescribed, even if you do not notice any immediate improvement, and attend all follow-up appointments so your healthcare provider can monitor your response to treatment.
Yes. Femara is used to treat certain types of hormone receptor-positive breast cancer in postmenopausal women. It may be prescribed as adjuvant (additional) therapy after surgery to help reduce the risk of the cancer returning, as extended adjuvant therapy following treatment with tamoxifen, or to treat advanced or metastatic breast cancer that has spread beyond the breast or has progressed after previous hormone therapy. Depending on your individual treatment plan, Femara may be used alone or in combination with other breast cancer treatments, such as surgery, radiation therapy, chemotherapy, or other medications.
| Generic name: | Letrozole |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 2.5mg |
| Quantities Available: | 28, 84, 90 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Femara (letrozole) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is standard for many prescription medications to ensure continuous treatment without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Femara is commonly prescribed in a dosage of 2.5 mg taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
Yes, we sell letrozole! You can enjoy affordable prices on your medication by ordering from our website. To place an order, you will need a valid prescription from your healthcare provider, as we require this to dispense the medication safely and accurately. You can conveniently submit your prescription by mail, fax, or by uploading it through your online account.
Yes, we ship Femara (letrozole) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Femara (Letrozole). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Femara (Letrozole).
REVIEWS